Cerebrospinal fluid 14-3-3-γ protein level in eight HIV-negative cryptococcal meningitis adults

European Journal of Neurology

Volumn 15, Issue 4, 2008, Pages 428-430

  Chang, W N ^a,b   Lu, C H ^a   Huang, C R ^a   Chuang, Y C ^a   Tsai, N W ^a   Chen, S F ^a   Chang, C C ^a   Wang, H C ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

14 3 3 protein; Cryptococcal meningitis

Indexed keywords

14,3,3 GAMMA PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCAL MENINGITIS; DENSITOMETRY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEUKOCYTE COUNT; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; SURVIVAL;

14-3-3 PROTEINS; ADULT; AGED; FEMALE; HIV SERONEGATIVITY; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED;

EID: 41049113833     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02091.x     Document Type: Article

References (9)

1. Bicanic T, Harrison TS. Cryptococcal meningitis. British Medical Bulletin 2005 72 : 99 118.
2. Lu CH, Chang WN, Chang HW, Chuang YC. The prognostic factors of cryptococcal meningitis in HIV-negative patients. The Journal of Hospital Infection 1999 42 : 313 320.
3. Berg D, Holzmann C, Riess O. 14-3-3 Proteins in the nervous system. Nature Reviews. Neuroscience 2003 4 : 752 762.
4. Shiga Y, Wakabayashi H, Miyazawa K, Kido H, Itoyama Y. 14-3-3 Protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages. Journal of Clinical Neuroscience 2006 13 : 661 665.
5. Green AJE, Thompson EJ, Stewart GE, et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery, and Psychiatry 2001 70 : 744 748.
6. Bonora S, Zanusso G, Raiteri R, et al. Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis. Clinical Infectious Diseases 2003 36 : 1492 1495.
7. Isobe T, Ichimura T, Sunaya T, et al. Distinct forms of the protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Journal of Molecular Biology 1991 217 : 125 132.
8. Chang WN, Lu CH, Chang HW, et al. Time course of cerebral hemodynamics in cryptococcal meningitis in HIV-negative adults. European Journal of Neurology 2007 14 : 770 776.
9. LiLiang PC, Liang CL, Chang WN, Lu K, Lu CH. Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus. Clinical Infectious Diseases 2002 34 : E64 E68.